Regelating protective immunity in atherosclerosis

Circulation Research

Volumn 96, Issue 4, 2005, Pages 395-397

  Nilsson, Jan ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Adaptive immunity; Lipoproteins; Oxidation; T cells

Indexed keywords

APOLIPOPROTEIN E; CD4 ANTIGEN; GAMMA INTERFERON; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; OXIDIZED LOW DENSITY LIPOPROTEIN; TOLL LIKE RECEPTOR; AUTOANTIGEN; CYTOKINE; DRUG DERIVATIVE; FREUND ADJUVANT; IMMUNOGLOBULIN RECEPTOR; LOW DENSITY LIPOPROTEIN; MALONALDEHYDE; MALONDIALDEHYDE LOW DENSITY LIPOPROTEIN, MOUSE; MALONDIALDEHYDE-LOW DENSITY LIPOPROTEIN, MOUSE; SCAVENGER RECEPTOR;

ANTIGEN PRESENTING CELL; ATHEROSCLEROSIS; AUTOIMMUNITY; EDITORIAL; HEART PROTECTION; IMMUNE RESPONSE; IMMUNOMODULATION; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; ANIMAL; ARTERIOSCLEROSIS; BIOSYNTHESIS; CD4+ T LYMPHOCYTE; DISEASE COURSE; GENETICS; HUMAN; IMMUNE DEFICIENCY; IMMUNIZATION; IMMUNOLOGY; INFLAMMATION; LYMPHOCYTE FUNCTION; METABOLISM; MOUSE; MOUSE MUTANT; NATURAL KILLER CELL; NOTE; SECRETION; TH1 CELL; TH2 CELL;

ANIMALS; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD4; APOLIPOPROTEINS E; ARTERIOSCLEROSIS; AUTOANTIGENS; CD4-POSITIVE T-LYMPHOCYTES; CYTOKINES; DISEASE PROGRESSION; FREUND'S ADJUVANT; HUMANS; IMMUNIZATION; IMMUNOGLOBULIN G; IMMUNOLOGIC DEFICIENCY SYNDROMES; INFLAMMATION; KILLER CELLS, NATURAL; LIPOPROTEINS, LDL; LYMPHOCYTE COOPERATION; MALONDIALDEHYDE; MICE; MICE, KNOCKOUT; MICE, MUTANT STRAINS; RECEPTORS, IMMUNOLOGIC; RECEPTORS, SCAVENGER; TH1 CELLS; TH2 CELLS;

EID: 14844349982     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.0000159183.88730.79     Document Type: Editorial

References (18)

1. Jonasson L, Holm J, Skalli O, Bondjers G, Hansson GK. Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis. 1986;6:131-138.
2. Binder CJ, Chang MK, Shaw PX, Miller YI, Hartvigsen K, Dewan A, Witztum JL. Innate and acquired immunity in atherogenesis. Nat Med. 2002;8:1218-1226.
3. Glass CK, Witztum JL. Atherosclerosis: the road ahead. Cell. 2001;104:503-516.
4. Stemme S, Faber B, Holm J, Wiklund O, Witztum JL, Hansson GK. T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein. Proc Natl Acad Sci U S A. 1995;92:3893-3897.
5. Palinski W, Miller E, Witztum JL. Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis. Proc Natl Acad Sci U S A. 1995;92:821-825.
6. Ameli S, Hultgårdh-Nilsson A, Regnström J, Calara F, Yano J, Cercek B, Shah PK, Nilsson J. Effect of immunization with homologous LDL on early atherosclerosis in hypercholesterolemic rabbits. Arteriosclerosis, Thrombosis and Vascular Biology. 1996;16:1074-1079.
7. Zhou X, Robertson AK, Rudling M, Parini P, Hansson GK. Lesion development and response to immunization reveal a complex role for CD4 in atherosclerosis. Circ Res. 2005;96:427-434.
8. Buono C, Pang H, Uchida Y, Libby P, Sharpe AH, Lichtman AH. B7-1/B7-2 costimulation regulates plaque antigen-specific T-cell responses and atherogenesis in low-density lipoprotein receptor-deficient mice. Circulation. 2004;109:2009-2015.
9. Bjorkbacka H, Kunjathoor VV, Moore KJ, Koehn S, Ordija CM, Lee MA, Means T, Halmen K, Luster AD, Golenbock DT, Freeman MW. Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways. Nat Med. 2004;10:416-421.
10. Tupin E, Nicoletti A, Elhage R, Rudling M, Ljunggren HG, Hansson GK, Berne GP. CD1d-dependent Activation of NKT Cells Aggravates Atherosclerosis. J Exp Med. 2004;199:417-422.
11. Elhage R, Gourdy P, Brauchet L, Jawien J, Fouque MJ, Fievet C, Huc X, Barreira Y, Couloumiers JC, Arnal JF, Bayard F. Deleting TCR alpha beta+ or CD4+ T lymphocytes leads to opposite effects on site-specific atherosclerosis in female apolipoprotein E-deficient mice. Am J Pathol. 2004;165:2013-2018.
12. Binder CJ, Hartvigsen K, Chang MK, Miller M, Broide D, Palinski W, Curtiss LK, Corr M, Witztum JL. IL-5 links adaptive and natural immunity specific for epitopes of oxidized LDL and protects from atherosclerosis. J Clin Invest. 2004;114:427-437.
13. Buono C, Binder CJ, Stavrakis G, Witztum JL, Glimcher LH, Lichtman AH. T-bet deficiency reduces atherosclerosis and alters plaque antigen-specific immune responses. Proc Natl Acad Sci U S A. In press.
14. Tyznik AJ, Sun JC, Bevan MJ. The CD8 population in CD4-deficient mice is heavily contaminated with MHC class II-restricted T cells. J Exp Med. 2004;199:559-565.
15. Killeen N, Sawada S, Littman DR. Regulated expression of human CD4 rescues helper T cell development in mice lacking expression of endogenous CD4. Embo J. 1993;12:1547-1553.
16. Locksley RM, Reiner SL, Hatam F, Littman DR, Killeen N. Helper T cells without CD4: control of leishmaniasis in CD4-deficient mice. Science. 1993;261:1448-1451.
17. Schiopu A, Bengfsson J, Soderberg I, Janciauskiene S, Lindgren S, Ares MP, Shah PK, Carlsson R, Nilsson J, Fredrikson GN. Recombinant human antibodies against aldehyde-modified apolipoprotein B-100 peptide sequences inhibit atherosclerosis. Circulation. 2004;110:2047-2052.
18. Fredrikson GN, Soderberg I, Lindholm M, Dimayuga P, Chyu KY, Shah PK, Nilsson J. Inhibition of atherosclerosis in apoE-null mice by immunization with apoB-100 peptide sequences. Arterioscler Thromb Vasc Biol. 2003;23:879-884.